MedTrace Logo

Optimization of the Care Pathway for Patients With Chronic Pain: Assessing the Value of Integrating Sleep Specialists

NCT06052384 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 664

Last updated 2025-07-30

No results posted yet for this study

Summary

DOLOREPIT is an interventional, RIPH 2, multicenter, randomized, controlled, open-label study comparing two care pathways for the management of patients with chronic pain.

Conditions

Interventions

OTHER

Standard pain management combined with sleep disorder management

Standard pain management combined with sleep disorder management at M6, and M12

Sponsors & Collaborators

  • Centre Hospitalier Emile Roux

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-07
Primary Completion
2027-06-30
Completion
2027-06-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06052384 on ClinicalTrials.gov